Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Locally Advanced or Metastatic Nasopharyngeal Carcinoma: a Prospective, Phase 2 Study
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 18 Apr 2016 Status changed from recruiting to completed.
- 17 Feb 2015 New trial record